Cytokinetics | CYTK - Net Income

Stock Price
65.04
Daily Change
0.10 0.15%
Monthly
4.20%
Yearly
88.14%
Q2 Forecast
64.72

Cytokinetics reported $-183.03M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Acadia Pharmaceuticals USD 273.57M 201.79M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
Arca Biopharma USD -29.58M 694K Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Eisai JPY 17.18B 7.02B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Exelixis USD 193.58M 8.73M Sep/2025
Geron USD -31.14M 12.72M Dec/2025
Halozyme Therapeutics USD -141.59M 316.82M Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
Ligand Pharmaceuticals USD 117.27M 112.43M Sep/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025